
Nizal S. Chandrakumar
Examiner (ID: 111, Phone: (571)272-6202 , Office: P/1625 )
| Most Active Art Unit | 1625 |
| Art Unit(s) | 1625 |
| Total Applications | 2819 |
| Issued Applications | 1922 |
| Pending Applications | 209 |
| Abandoned Applications | 730 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16402187
[patent_doc_number] => 20200343045
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-29
[patent_title] => YANLI DIELECTRIC MATERIALS AND CAPACITOR THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/924809
[patent_app_country] => US
[patent_app_date] => 2020-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15247
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16924809
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/924809 | YANLI DIELECTRIC MATERIALS AND CAPACITOR THEREOF | Jul 8, 2020 | Abandoned |
Array
(
[id] => 17807369
[patent_doc_number] => 20220259204
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => A PROCESS FOR THE PREPARATION OF VENETOCLAX AND ITS POLYMORPHS THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/626078
[patent_app_country] => US
[patent_app_date] => 2020-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2625
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17626078
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/626078 | A PROCESS FOR THE PREPARATION OF VENETOCLAX AND ITS POLYMORPHS THEREOF | Jul 7, 2020 | Pending |
Array
(
[id] => 16569019
[patent_doc_number] => 20210008025
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-14
[patent_title] => System and Method for Making Cannabinoid Nanoparticle Carrier Composition
[patent_app_type] => utility
[patent_app_number] => 16/946838
[patent_app_country] => US
[patent_app_date] => 2020-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1319
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 130
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16946838
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/946838 | System and method for making cannabinoid nanoparticle carrier composition | Jul 7, 2020 | Issued |
Array
(
[id] => 20315992
[patent_doc_number] => 12454534
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-28
[patent_title] => Pyrrolo[2,3-b]pyrazines as HPK1 inhibitor and the use thereof
[patent_app_type] => utility
[patent_app_number] => 17/623732
[patent_app_country] => US
[patent_app_date] => 2020-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25167
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17623732
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/623732 | Pyrrolo[2,3-b]pyrazines as HPK1 inhibitor and the use thereof | Jul 2, 2020 | Issued |
Array
(
[id] => 17981114
[patent_doc_number] => 20220347150
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-03
[patent_title] => TASIMELTEON USE IN TREATING SLEEP ABERRATIONS
[patent_app_type] => utility
[patent_app_number] => 17/621447
[patent_app_country] => US
[patent_app_date] => 2020-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3282
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -37
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17621447
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/621447 | TASIMELTEON USE IN TREATING SLEEP ABERRATIONS | Jun 28, 2020 | Pending |
Array
(
[id] => 18134723
[patent_doc_number] => 11560376
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-24
[patent_title] => Amino acid compounds and methods of use
[patent_app_type] => utility
[patent_app_number] => 16/914209
[patent_app_country] => US
[patent_app_date] => 2020-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 48
[patent_figures_cnt] => 2
[patent_no_of_words] => 100648
[patent_no_of_claims] => 79
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 568
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16914209
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/914209 | Amino acid compounds and methods of use | Jun 25, 2020 | Issued |
Array
(
[id] => 17799004
[patent_doc_number] => 11413270
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-16
[patent_title] => Method for the treatment of pancreatitis
[patent_app_type] => utility
[patent_app_number] => 16/908195
[patent_app_country] => US
[patent_app_date] => 2020-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 12
[patent_no_of_words] => 9018
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16908195
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/908195 | Method for the treatment of pancreatitis | Jun 21, 2020 | Issued |
Array
(
[id] => 16523724
[patent_doc_number] => 20200397804
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-24
[patent_title] => TREATMENT AND PREVENTION OF NEURODEGENERATIVE DISORDERS
[patent_app_type] => utility
[patent_app_number] => 16/907210
[patent_app_country] => US
[patent_app_date] => 2020-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6650
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16907210
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/907210 | TREATMENT AND PREVENTION OF NEURODEGENERATIVE DISORDERS | Jun 19, 2020 | Abandoned |
Array
(
[id] => 17297780
[patent_doc_number] => 20210393619
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-23
[patent_title] => VAGINAL GEL
[patent_app_type] => utility
[patent_app_number] => 16/904678
[patent_app_country] => US
[patent_app_date] => 2020-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2465
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16904678
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/904678 | Vaginal gel | Jun 17, 2020 | Issued |
Array
(
[id] => 20671876
[patent_doc_number] => 12612376
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-04-28
[patent_title] => Process for synthesizing 5-hydroxymethylfurfural
[patent_app_type] => utility
[patent_app_number] => 17/622283
[patent_app_country] => US
[patent_app_date] => 2020-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1545
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17622283
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/622283 | Process for synthesizing 5-hydroxymethylfurfural | Jun 14, 2020 | Issued |
Array
(
[id] => 16326745
[patent_doc_number] => 20200297710
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-24
[patent_title] => Chemical Compounds
[patent_app_type] => utility
[patent_app_number] => 16/898667
[patent_app_country] => US
[patent_app_date] => 2020-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34989
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 393
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16898667
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/898667 | Chemical compounds | Jun 10, 2020 | Issued |
Array
(
[id] => 17421233
[patent_doc_number] => 11254674
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-02-22
[patent_title] => Inhibiting CREB binding protein (CBP)
[patent_app_type] => utility
[patent_app_number] => 16/946159
[patent_app_country] => US
[patent_app_date] => 2020-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 1
[patent_no_of_words] => 12491
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16946159
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/946159 | Inhibiting CREB binding protein (CBP) | Jun 7, 2020 | Issued |
Array
(
[id] => 18156533
[patent_doc_number] => 11569530
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-31
[patent_title] => Silicon-based energy storage devices with functional thiophene compounds or derivatives of thiophene containing electrolyte additives
[patent_app_type] => utility
[patent_app_number] => 16/890576
[patent_app_country] => US
[patent_app_date] => 2020-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 11295
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16890576
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/890576 | Silicon-based energy storage devices with functional thiophene compounds or derivatives of thiophene containing electrolyte additives | Jun 1, 2020 | Issued |
Array
(
[id] => 16482342
[patent_doc_number] => 20200375942
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-03
[patent_title] => METHOD OF TREATING STIMULANT USE DISORDER USING A COMBINATION OF TOPIRAMATE AND PHENTERMINE
[patent_app_type] => utility
[patent_app_number] => 16/889320
[patent_app_country] => US
[patent_app_date] => 2020-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12127
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16889320
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/889320 | Method of treating stimulant use disorder using a combination of topiramate and phentermine | May 31, 2020 | Issued |
Array
(
[id] => 18044908
[patent_doc_number] => 11518849
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-12-06
[patent_title] => Post polymerization modification in flow
[patent_app_type] => utility
[patent_app_number] => 16/882028
[patent_app_country] => US
[patent_app_date] => 2020-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 22
[patent_no_of_words] => 18377
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16882028
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/882028 | Post polymerization modification in flow | May 21, 2020 | Issued |
Array
(
[id] => 16297685
[patent_doc_number] => 20200283408
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-10
[patent_title] => BENZIMIDAZOLE-CARBOXAMIDE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS
[patent_app_type] => utility
[patent_app_number] => 16/881209
[patent_app_country] => US
[patent_app_date] => 2020-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18733
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16881209
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/881209 | Benzimidazole-carboxamide compounds as 5-HT | May 21, 2020 | Issued |
Array
(
[id] => 16296229
[patent_doc_number] => 20200281952
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-10
[patent_title] => SUBSTITUTED BICYCLIC COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/879824
[patent_app_country] => US
[patent_app_date] => 2020-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 58448
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16879824
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/879824 | Substituted bicyclic compounds | May 20, 2020 | Issued |
Array
(
[id] => 18240372
[patent_doc_number] => 20230072683
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-09
[patent_title] => PYRIDO-PYRIMIDIN DERIVATIVES AND PHARMACEUTICAL COMPOSITION, FOR USE IN PREVENTING OR TREATING PI3 KINASE RELATED DISEASES, COMPRISING SAME AS ACTIVE INGREDIENT
[patent_app_type] => utility
[patent_app_number] => 17/612740
[patent_app_country] => US
[patent_app_date] => 2020-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33185
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17612740
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/612740 | PYRIDO-PYRIMIDIN DERIVATIVES AND PHARMACEUTICAL COMPOSITION, FOR USE IN PREVENTING OR TREATING PI3 KINASE RELATED DISEASES, COMPRISING SAME AS ACTIVE INGREDIENT | May 18, 2020 | Abandoned |
Array
(
[id] => 16450880
[patent_doc_number] => 20200360306
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-19
[patent_title] => USE OF CO-CRYSTALS OF TRAMADOL AND CELECOXIB FOR TREATING PAIN WHILE REDUCING THE ABUSE LIABILITY OF TRAMADOL
[patent_app_type] => utility
[patent_app_number] => 15/931681
[patent_app_country] => US
[patent_app_date] => 2020-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13124
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15931681
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/931681 | USE OF CO-CRYSTALS OF TRAMADOL AND CELECOXIB FOR TREATING PAIN WHILE REDUCING THE ABUSE LIABILITY OF TRAMADOL | May 13, 2020 | Abandoned |
Array
(
[id] => 20372397
[patent_doc_number] => 12479819
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-25
[patent_title] => Method and compound useful in preparation of orexin-2 receptor antagonist, and lemborexant having few impurities
[patent_app_type] => utility
[patent_app_number] => 17/604527
[patent_app_country] => US
[patent_app_date] => 2020-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8902
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17604527
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/604527 | Method and compound useful in preparation of orexin-2 receptor antagonist, and lemborexant having few impurities | May 12, 2020 | Issued |